Bile acid derivatives as FXR ligands for the prevention or treatment of FXRmediated diseases or conditions

Details for Australian Patent Application No. 2007265457 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pruzanski, Mark; Pellicciari, Roberto; Fiorucci, Stefano

Agent Cullens

Pub. Number AU-B-2007265457

PCT Pub. Number WO2008/002573

Priority 60/816,635 27.06.06 US

Filing date 27 June 2007

Wipo publication date 3 January 2008

Acceptance publication date 14 June 2012

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/002573 Priority application(s): WO2008/002573

14 June 2012 Application Accepted

  Published as AU-B-2007265457

9 August 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Jul 2012 . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007265460-Prolyl hydroxylase inhibitors and methods of use

2007265455-Human protein tyrosine phosphatase inhibitors and methods of use